Eyestem to start human trials for its dry AMD treatment
Eyestem’s Eyecyte RPE therapy aims to replace lost or damaged retinal pigment epithelium (RPE) cells
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.